Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists

Robert Adam1,2, Gabriela Neculae1, Claudiu Stan2,3

  • 1Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, "Prof. Dr. C.C. Iliescu" Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania.

Insights

Cardiac amyloidosis (CA) is increasingly recognized, yet Romanian cardiologists show varied knowledge and limited experience. Educational initiatives are crucial to improve early diagnosis and treatment of this condition.

Area of Science:

  • Cardiology
  • Amyloidosis Research
  • Medical Education

Background:

  • Cardiac amyloidosis (CA) is a restrictive cardiomyopathy caused by amyloid deposition in the heart muscle.
  • Recent studies indicate CA is more prevalent than previously thought.
  • Advances in diagnosis and treatment necessitate prompt identification of CA.

Purpose of the Study:

  • To assess the current knowledge and experience of Romanian cardiologists regarding cardiac amyloidosis.
  • To identify gaps in understanding CA, including specific types like transthyretin amyloidosis (ATTRwt and ATTRv).
  • To highlight educational needs for improving CA diagnosis and management.

Main Methods:

  • An online survey was distributed to cardiologists in Romania.
  • 195 cardiologists completed the questionnaire on their knowledge and experience with CA.
  • The survey assessed awareness of CA prevalence, diagnosis, and treatment options.

Main Results:

  • Significant variation in knowledge about CA was observed among participants.
  • Romanian cardiologists reported limited experience with CA and noted delays in diagnosis.
  • Gaps were identified in understanding ATTRwt and ATTRv prevalence, diagnosis, and treatment.

Conclusions:

  • Cardiologist awareness is a key challenge in diagnosing CA.
  • Romanian cardiologists possess partial awareness but require further education on CA.
  • Targeted educational programs can enhance patient screening and improve outcomes for CA.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
145
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
110
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
170
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
109